Franco-Dutch airline Air France KLM Martinair Cargo (AFKLMP) has been awarded IATA CEIV Pharma certification for the Air France and KLM airline processes and its Charles de Gaulle and Schiphol hub operations.
The carrier has also drafted a three-year strategy to achieve growth in the pharmaceutical segment. In addition to strengthening its digital and booking tools, it will invest in further expanding its cold-chain capacity and operational quality.
Adriaan den Heijer, executive vice president of Air France KLM Cargo and managing director of Martinair said: “The pharmaceutical segment forms a strategic part of our business in which we continuously invest. The IATA CEIV Pharma recertification demonstrates once again that we have the right expertise, processes and facilities in place. We will make additional investments this year in our facilities, digital services and people to further strengthen our proposition for our pharmaceutical customers.”
AFKLMP Cargo became the first airline group to be CEIV Pharma certified. In 2016 Nick Careen, IATA senior vice president operations, safety and security said: “The European freight market is one of the largest in the world, accounting for close to a quarter of total global trade. Having Air France KLM Martinair Cargo, one of the region’s largest cargo operators, achieve CEIV Pharma Certification at two of Europe’s largest airports, for the third time, is a testament to the company’s reliable handling of pharma shipments.”